Arginine therapy in sickle cell disease: A systematic review and meta-analysis of clinical outcomes.
- 2026-04
- Meta-Analysis · n = 830
- Clinical nutrition ESPEN 72
- Favour M L Foncha
- Joseph Y Bena Nnang
- Samuel G J Fodop
- Best C I Poudjoum
- Dimitri S Tcheuko
- Joel G K Mekontso
- PubMed: 41534622
- DOI: 10.1016/j.clnesp.2025.102898
- High evidence
- Clinical
A non-significant 23 % increase in hospital readmission risk was observed (RR 1.23, 95 % CI [0.92, 1.65])
- Effect
- Neutral
- Effect size
- Small
- Significant
- No